Back

Chronic pain exacerbates nicotine withdrawal severity in a sex-specific and dose-dependent manner

Graham, B.; Nelson, T.; Tavakoli, S.; O'Dell, L.; Addy, N. A.; Bagdas, D.

2026-04-21 pharmacology and toxicology
10.64898/2026.04.16.719070 bioRxiv
Show abstract

Chronic pain and nicotine use frequently co-occur, and individuals with chronic pain often experience greater difficulty quitting. Therefore, we examined nicotine withdrawal behaviors and analgesic-like effects in pain-naive and chronic pain conditions. Adult male and female rats underwent chronic constriction injury or sham surgery. After pain establishment, rats received twice-daily subcutaneous nicotine (0.3 or 0.7 mg/kg) or saline for 14 days. 24 h after the final injection, withdrawal was assessed, including physical signs and anxiety-like behavior. Depressive-like responses were evaluated at 72 h. Pain sensitivity and nicotines analgesic-like effects were assessed throughout. Chronic pain increased physical signs of withdrawal in both sexes, with greater effects in females. It also induced anxiety-like behavior in controls of both sexes. In rats with comorbid chronic pain and withdrawal, anxiety-like behavior was further enhanced in males, whereas females showed variable responses across assays, with increases or decreases depending on the test. Chronic pain induced depressive-like behavior in males but not in females. During withdrawal, depressive-like responses in males with chronic pain were not greater than those in the chronic pain alone group, while chronic nicotine exposure reduced depressive-like behavior in females. Nicotine produced acute analgesic-like effects that diminished over time in both pain-naive and chronic pain conditions, indicating tolerance. In pain-naive rats, repeated nicotine exposure induced mechanical hypersensitivity. Chronic pain intensified nicotine withdrawal severity in a nicotine concentration- and sex-dependent manner. These findings highlight the importance of considering pain status and sex when developing effective cessation strategies, particularly for individuals with comorbid chronic pain. SummaryChronic pain exacerbates nicotine withdrawal severity. Chronic nicotine exposure induces pain hypersensitivity and tolerance to analgesic effects. These effects vary by nicotine concentration and sex.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Psychopharmacology
59 papers in training set
Top 0.1%
18.8%
2
British Journal of Pharmacology
34 papers in training set
Top 0.1%
12.4%
3
Neuropharmacology
60 papers in training set
Top 0.1%
10.1%
4
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
6.8%
5
PLOS ONE
4510 papers in training set
Top 28%
6.3%
50% of probability mass above
6
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
4.3%
7
Frontiers in Pharmacology
100 papers in training set
Top 0.7%
4.0%
8
Scientific Reports
3102 papers in training set
Top 31%
4.0%
9
Drug and Alcohol Dependence
37 papers in training set
Top 0.3%
3.6%
10
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.1%
2.1%
11
Nicotine & Tobacco Research
11 papers in training set
Top 0.1%
1.3%
12
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.3%
13
Neuropsychopharmacology
134 papers in training set
Top 2%
1.3%
14
Journal of Psychiatric Research
28 papers in training set
Top 0.5%
1.3%
15
Journal of Psychopharmacology
14 papers in training set
Top 0.3%
1.3%
16
Nicotine and Tobacco Research
13 papers in training set
Top 0.2%
1.2%
17
Behavioural Brain Research
70 papers in training set
Top 0.8%
1.1%
18
The Journal of Pain
26 papers in training set
Top 0.5%
0.9%
19
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1%
0.9%
20
Pain
70 papers in training set
Top 0.7%
0.8%
21
eLife
5422 papers in training set
Top 55%
0.8%
22
Pharmaceuticals
33 papers in training set
Top 2%
0.7%
23
Translational Psychiatry
219 papers in training set
Top 4%
0.7%
24
Biomedicines
66 papers in training set
Top 4%
0.6%
25
Neurotherapeutics
11 papers in training set
Top 0.7%
0.6%